Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Oil prices post weekly gain ahead of OPEC+ meeting

11/27/2020 | 01:13am EST

* Brent rises 7.2% in week; WTI gains 8%

* OPEC+ leaning towards oil cut extension, despite rally -sources

* Questions over AstraZeneca vaccine, scientists sound caution

NEW YORK, Nov 27 (Reuters) - Oil prices were mixed on Friday but posted a fourth straight week of gains ahead of an OPEC+ meeting early next week.

Brent crude January futures rose 38 cents to settle at $48.18 a barrel, while the more active February contract gained 46 cents to $48.25.

U.S. West Texas Intermediate (WTI) crude futures fell 18 cents to settle at $45.53 a barrel.

Brent rose 7.2% over the week, while WTI gained 8% for the week. Encouraging news on potential COVID-19 vaccines from AstraZeneca and others have lifted the markets. However, questions have been raised over AstraZeneca's "vaccine for the world," with several scientists sounding caution over the trial results.

"While a successful vaccine rollout should break the link between infection and mobility, even then global oil demand will likely only reach its pre-pandemic run rate by mid-2022," JP Morgan said.

The Organization of the Petroleum Exporting Countries (OPEC) and allies including Russia are leaning towards delaying next year's planned increase in oil output, said three sources close to the OPEC+ group.

OPEC+ was planning to raise output by 2 million barrels per day (bpd) in January - about 2% of global consumption - after record supply cuts this year. OPEC+ ministers are due to meet from Monday.

"The market expects prices to see a limited increase if OPEC+ indeed does what is expected and changes its planned route, postponing a planned supply increase from January," said Bjornar Tonhaugen, Rystad Energy's head of oil markets

A panel of OPEC+ will hold informal online talks on Sunday - a day later than scheduled, a source with the knowledge of the matter told Reuters.

Rising Libyan output is also contributing to concerns about oversupply in the market.

The OPEC member, which is exempt from the oil cuts, has added more than 1.1 million bpd of output since early September.

(Reporting by Stephanie Kelly in New York; additional reporting by Ahmad Ghaddar in London and Aaron Sheldrick in Tokyo Editing by Marguerita Choy and Louise Heavens)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.92% 7678 Delayed Quote.4.62%
LONDON BRENT OIL 0.35% 54.95 Delayed Quote.9.17%
US DOLLAR / RUSSIAN ROUBLE (USD/RUB) -0.08% 73.751 Delayed Quote.-0.05%
WTI -0.20% 52.191 Delayed Quote.11.60%
All news about ASTRAZENECA PLC
01/18Philippines to buy 20 mln doses of Moderna's COVID-19 vaccine
RE
01/18Britain Faces COVID-19 Vaccine Supply Delays, Remains On Course To Achieve Va..
MT
01/18Mexico aims to make up for Pfizer vaccine shortfall with others
RE
01/18Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use
RE
01/18ASTRAZENECA : Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency..
RE
01/18Mexico aims to make up for Pfizer vaccine shortfall with others
RE
01/18Does Getting the Covid-19 Vaccine Stop You Spreading It? Scientists Don't Kno..
DJ
01/18Indian companies consider buying vaccines for employees
RE
01/18WHO says close to Pfizer deal that would give poorer countries access
RE
01/18South Africa to get 9 million J&J vaccine shots - ministry
RE
More news
Financials (USD)
Sales 2020 26 400 M - -
Net income 2020 2 970 M - -
Net Debt 2020 13 217 M - -
P/E ratio 2020 40,8x
Yield 2020 2,71%
Capitalization 137 B 137 B -
EV / Sales 2020 5,67x
EV / Sales 2021 4,92x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 126,16 $
Last Close Price 104,06 $
Spread / Highest target 50,0%
Spread / Average Target 21,2%
Spread / Lowest Target -19,2%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC4.62%136 529
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993